On November 3, 2021, the Drug, Chemical & Associated Technologies Association (DCAT) announced preliminary plans for its flagship event, DCAT Week, including confirmation that the event will take place in…
Stay up-to-date on the latest in-depth analysis on issues impacting the business of pharmaceutical development and manufacturing—on the go! We are pleased to offer the DCAT Value Chain Insights podcast,…
Focus of 2022 DCAT Research & Benchmarking Report is Announced
Evaluate your company’s best practices and learn from industry peers with DCAT Research & Benchmarking reports. Beginning this month, DCAT’s Research and Benchmarking Committee will begin distributing its 2022 survey…
5 MINUTES WITH: Margaret Timony, Executive Director, DCAT
DCAT Value Chain Insights’ “5 Minutes With,” part of the new DCAT Member Community section, features interviews with industry leaders on issues impacting the bio/pharmaceutical manufacturing value chain and other business…
5 MINUTES WITH: John Ratliff, Chairman and CEO, Curia
DCAT Value Chain Insights’ “5 Minutes With,” part of the new DCAT Member Community section, features interviews with industry leaders on issues impacting the bio/pharmaceutical manufacturing value chain and other business…
The DCAT organization is pleased to announce the members of its Board of Directors for the upcoming fiscal year, November 1, 2021, to October 31, 2022. The members were interviewed…
Now Available: Women Leaders in Pharma Interview Series eBook
In late 2020, the DCAT Alliance for Industry Women Committee introduced its Women Leaders in Pharma: An Interview Series. This series allows readers to hear from key industry colleagues who have…
Message from Outgoing DCAT Board President Sean Diver
To the DCAT Member Community: As my tenure as President of the Board of Directors of the DCAT organization comes to a close, I want to take this opportunity to…
DCAT Value Chain Insights’ “5 Minutes With,” part of the new DCAT Member Community section, features interviews with industry leaders on issues impacting the bio/pharmaceutical manufacturing value chain and other…
